Telmisartan for treatment of Covid-19 patients: An open mu | UPDATES IN MEDICINE
Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial
● Interpretation - Our study suggests that the ARB telmisartan, a widely used antihypertensive drug, is safe and could reduce morbidity and mortality in hospitalized patients infected with SARS -CoV-2 by anti-inflammatory effects.
